Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 141

1.

The metabolic programming of stem cells.

Shyh-Chang N, Ng HH.

Genes Dev. 2017 Feb 15;31(4):336-346. doi: 10.1101/gad.293167.116. Epub 2017 Mar 17. Review.

PMID:
28314766
2.

DNA repair and replication links to pluripotency and differentiation capacity of pig iPS cells.

Liu K, Mao J, Song L, Fan A, Zhang S, Wang J, Fan N, Liu N, Ye X, Fu H, Zhou Z, Wang Y, Wei H, Liu Z, Li Z, Lai L, Wang X, Liu L.

PLoS One. 2017 Mar 2;12(3):e0173047. doi: 10.1371/journal.pone.0173047. eCollection 2017.

3.

Core Transcription Factors, MicroRNAs, and Small Molecules Drive Transdifferentiation of Human Fibroblasts Towards The Cardiac Cell Lineage.

Christoforou N, Chakraborty S, Kirkton RD, Adler AF, Addis RC, Leong KW.

Sci Rep. 2017 Jan 10;7:40285. doi: 10.1038/srep40285.

4.

Novel HDAd/EBV Reprogramming Vector and Highly Efficient Ad/CRISPR-Cas Sickle Cell Disease Gene Correction.

Li C, Ding L, Sun CW, Wu LC, Zhou D, Pawlik KM, Khodadadi-Jamayran A, Westin E, Goldman FD, Townes TM.

Sci Rep. 2016 Jul 27;6:30422. doi: 10.1038/srep30422.

5.

β-Cell regeneration through the transdifferentiation of pancreatic cells: Pancreatic progenitor cells in the pancreas.

Kim HS, Lee MK.

J Diabetes Investig. 2016 May;7(3):286-96. doi: 10.1111/jdi.12475. Epub 2016 Feb 29. Review.

6.

Enhanced Generation of Integration-free iPSCs from Human Adult Peripheral Blood Mononuclear Cells with an Optimal Combination of Episomal Vectors.

Wen W, Zhang JP, Xu J, Su RJ, Neises A, Ji GZ, Yuan W, Cheng T, Zhang XB.

Stem Cell Reports. 2016 Jun 14;6(6):873-84. doi: 10.1016/j.stemcr.2016.04.005. Epub 2016 May 5.

7.

Optimized Approaches for Generation of Integration-free iPSCs from Human Urine-Derived Cells with Small Molecules and Autologous Feeder.

Li D, Wang L, Hou J, Shen Q, Chen Q, Wang X, Du J, Cai X, Shan Y, Zhang T, Zhou T, Shi X, Li Y, Zhang H, Pan G.

Stem Cell Reports. 2016 May 10;6(5):717-28. doi: 10.1016/j.stemcr.2016.04.001. Epub 2016 Apr 28.

8.

Human induced pluripotent stem cells for monogenic disease modelling and therapy.

Spitalieri P, Talarico VR, Murdocca M, Novelli G, Sangiuolo F.

World J Stem Cells. 2016 Apr 26;8(4):118-35. doi: 10.4252/wjsc.v8.i4.118. Review.

9.

Rationale and Methodology of Reprogramming for Generation of Induced Pluripotent Stem Cells and Induced Neural Progenitor Cells.

Tian Z, Guo F, Biswas S, Deng W.

Int J Mol Sci. 2016 Apr 20;17(4). pii: E594. doi: 10.3390/ijms17040594. Review.

10.

Microbial metabolite butyrate facilitates M2 macrophage polarization and function.

Ji J, Shu D, Zheng M, Wang J, Luo C, Wang Y, Guo F, Zou X, Lv X, Li Y, Liu T, Qu H.

Sci Rep. 2016 Apr 20;6:24838. doi: 10.1038/srep24838.

11.

Human induced pluripotent stem cell-derived cardiomyocytes recapitulate the predilection of breast cancer patients to doxorubicin-induced cardiotoxicity.

Burridge PW, Li YF, Matsa E, Wu H, Ong SG, Sharma A, Holmström A, Chang AC, Coronado MJ, Ebert AD, Knowles JW, Telli ML, Witteles RM, Blau HM, Bernstein D, Altman RB, Wu JC.

Nat Med. 2016 May;22(5):547-56. doi: 10.1038/nm.4087. Epub 2016 Apr 18.

12.

iPSCs: A Minireview from Bench to Bed, including Organoids and the CRISPR System.

Orqueda AJ, Giménez CA, Pereyra-Bonnet F.

Stem Cells Int. 2016;2016:5934782. doi: 10.1155/2016/5934782. Epub 2016 Jan 6. Review.

13.

Histone H4 acetylation and the epigenetic reader Brd4 are critical regulators of pluripotency in embryonic stem cells.

Gonzales-Cope M, Sidoli S, Bhanu NV, Won KJ, Garcia BA.

BMC Genomics. 2016 Feb 4;17:95. doi: 10.1186/s12864-016-2414-y.

14.

An Overview of Direct Somatic Reprogramming: The Ins and Outs of iPSCs.

Menon S, Shailendra S, Renda A, Longaker M, Quarto N.

Int J Mol Sci. 2016 Jan 21;17(1). pii: E141. doi: 10.3390/ijms17010141. Review.

15.

Pluripotent Stem Cells: Current Understanding and Future Directions.

Romito A, Cobellis G.

Stem Cells Int. 2016;2016:9451492. doi: 10.1155/2016/9451492. Epub 2015 Dec 20. Review.

17.

H3K9me3-Dependent Heterochromatin: Barrier to Cell Fate Changes.

Becker JS, Nicetto D, Zaret KS.

Trends Genet. 2016 Jan;32(1):29-41. doi: 10.1016/j.tig.2015.11.001. Epub 2015 Dec 8. Review.

18.

Non-integrating episomal plasmid-based reprogramming of human amniotic fluid stem cells into induced pluripotent stem cells in chemically defined conditions.

Slamecka J, Salimova L, McClellan S, van Kelle M, Kehl D, Laurini J, Cinelli P, Owen L, Hoerstrup SP, Weber B.

Cell Cycle. 2016;15(2):234-49. doi: 10.1080/15384101.2015.1121332.

19.

Reprogramming barriers and enhancers: strategies to enhance the efficiency and kinetics of induced pluripotency.

Ebrahimi B.

Cell Regen (Lond). 2015 Nov 11;4:10. doi: 10.1186/s13619-015-0024-9. eCollection 2015.

20.

Mesenchymal and induced pluripotent stem cells: general insights and clinical perspectives.

Zomer HD, Vidane AS, Gonçalves NN, Ambrósio CE.

Stem Cells Cloning. 2015 Sep 28;8:125-34. doi: 10.2147/SCCAA.S88036. eCollection 2015. Review.

Supplemental Content

Support Center